GlaxoSmithKline PLC GSK Transaction in Own Shares

  GlaxoSmithKline PLC (GSK) - Transaction in Own Shares

RNS Number : 9436R
GlaxoSmithKline PLC
23 November 2012
 



GlaxoSmithKline plc  (the  Company)  announces that  in  accordance  with  the 
authority granted by shareholders at the Company's Annual General Meeting on 3
May 2012 it purchased 781,750 of its Ordinary Shares of 25 pence each (Shares)
on 23 November 2012.

 

The highest price paid per Share was 1,349.0 pence per Share.

 

The lowest price paid per Share was 1,335.5 pence per Share.

 

The Shares will be cancelled.

 

The Company holds 490,140,427 of its Shares in Treasury, representing 9.07% of
the total issued share capital of the Company. 

 

Including Shares which have  been purchased but not  yet settled, the  Company 
holds 490,140,427 of its Shares in  Treasury, representing 9.98% of the  total 
voting rights in the Company.

 

The Company  has  4,912,015,214 Shares  in  issue (excluding  Shares  held  in 
Treasury). This number represents the total  voting rights in the Company  and 
may be used by shareholders as  the denominator for the calculations by  which 
they can determine  if they are  required to  notify their interest  in, or  a 
change to  their  interest  in,  the  Company  under  the  Financial  Services 
Authority's Disclosure and Transparency Rules.

 

This announcement  does not  constitute, or  form  part of,  an offer  or  any 
solicitation of  an offer  to  purchase or  subscribe  for securities  in  any 
jurisdiction and  is in  conformity with  the Financial  Services  Authority's 
Disclosure and Transparency Rules.

                     This information is provided by RNS
           The company news service from the London Stock Exchange
 
END
 
 
POSLLFEDLDLVFIF -0- Nov/23/2012 17:58 GMT